Free shipping on all orders over $ 500

Enapotamab vedotin

Cat. No. M58982

All AbMole products are for research use only, cannot be used for human consumption.

Enapotamab vedotin Structure
Size Price Availability Quantity
100ug USD 600  USD600 In stock
1mg USD 1400  USD1400 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
  • Purity: >99.0%, Endotoxin < 1 EU/µg
  • COA
  • MSDS
Biological Activity

Enapotamab vedotin is an AXL-targeted antibody-drug conjugate (ADC) with inhibitory potential against high AXL expressing non-small cell lung cancer (NSCLC).

Human AXL / UFO HEK293 Cell Line were stained with enapotamab vedotin and negative control protein respectively, washed and then followed by PE and analyzed with FACS, the EC50 is 0.16 ug/mL.

Enapotamab vedotin (2-4 mg/kg; iv, once weekly for 2 doses) inhibited the tumor growth in LU0395 xenograft mouse models.

Chemical Information
CAS Number 1912424-97-5
Storage Store at ≤ -20℃ for up to 24 months. Avoid repeated freeze-thaw cycles.
Related Antibody-Drug Conjugates (ADCs) Products
Glembatumumab vedotin

Glembatumumab vedotin (CDX-011) is an antibody-drug conjugate (ADC) comprising a fully human IgG2 monoclonal antibody (CR011) directed against glycoprotein NMB (GPNMB) and conjugated to the potent tubulinbinding cytotoxic agent MMAE via a protease-sensitive vc linker. Glembatumumab vedotin has potent anticancer effects.

Denintuzumab-MMAF

Denintuzumab-MMAF is an antibody-drug conjugate (ADC). Codrituzumab is a monoclonal antibody targeting GPC3 (glypican-3). Denintuzumab (hBU 12) is a recombinant humanized anti-CD19 monoclonal antibody. Denintuzumab binds to CD19 on the surface of B cells.

Codrituzumab-MMAE (CHO)

Codrituzumab-MMAE is an antibody-drug conjugate (ADC). Codrituzumab is a monoclonal antibody targeting GPC3 (glypican-3).

Tisotumab Vedotin

Tisotumab Vedotin is a tissue factor-directed antibody-drug conjugate (ADC) containing a tissue factor-specific fully human monoclonal antibody (TF-011) conjugated to monomethylmethane auristatin E (MMAE), which can be used in studies related to cervical cancer.

Vandortuzumab vedotin

Vandortuzumab vedotin (DSTP 3086S) is an antibody-drug-conjugate to target prostate cancer.

  Catalog
Abmole Inhibitor Catalog




Keywords: Enapotamab vedotin supplier, Antibody-Drug Conjugates (ADCs), inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.